Research, Business Insights

Vendor Partnering in a Bioprocess Manufacturing and Supply Chain Ecosystem

October 14, 2022

Vendor Partnering
Supply constancy, cost, sterility – even a subset of
the factors that impact materials selection can be
daunting for biopharmaceutical companies embarking on a new drug development project. 

Spotlight

Britannia Pharmaceuticals Ltd

Founded in 1981, Britannia Pharmaceuticals Limited is a UK based niche pharmaceutical company specialising in products for diseases with small patient populations which are normally not developed by larger pharmaceutical companies. Subsequent to acquisition Britannia is now part of the STADA group of companies.

OTHER WHITEPAPERS
news image

Streamlining Distribution in the Pharmaceutical Industry

whitePaper | November 25, 2022

Satyendra Sinha is a Functional Consultant with the TCS Life Sciences unit, and focuses on order management, distribution.

Read More
news image

Achieving diversity, equity and inclusion in clinical trials

whitePaper | April 26, 2022

The prevalence of communicable and non-communicable diseases are increasing worldwide, placing considerable demand on public health systems and driving a necessity to develop more effective targeted therapies.

Read More
news image

Access to medicinal products

whitePaper | January 3, 2022

There are many factors that can prevent a patient from being able to obtain the medicine they need, ranging from selective marketing decisions by companies to products being too expensive or pharmacy stock-outs

Read More
news image

The Never-Normal Future of Manufacturing

whitePaper | September 24, 2022

Let’s just say what we’re all thinking: 2020 was rough. It threw pretty much every element of our lives into disarray, and we suddenly had to become experts at navigating a new way of working, schooling and socializing.

Read More
news image

2022 Global Life Sciences Outlook

whitePaper | January 3, 2022

While valuations for the life sciences sector in this past year have been mixed, the underlying performance and outlook for the

Read More
news image

A Vision for the Global Generic and Biosimilar Medicines Industry

whitePaper | May 22, 2021

One of the key roles of the generic and biosimilar medicines industry is specifically to promote the widest possible access to affordable medicines with high quality, safety, and efficacy for patients globally by introducing competition into the markets. Despite the many hurdles, the generic medicines companies have clearly lived up to the challenges posed by the pandemic as it is an industry that is quick to adapt and agile in manufacturing scale-up. During the outbreak of COVID-19, this industry was providing most of the medicines needed in Intensive Care Units to ventilate critically ill COVID patients. It is also providing most of the quality medicines dispensed around the world, especially for increasingly prevalent chronic diseases and is therefore a strong contributor to health outcomes globally.

Read More

Spotlight

Britannia Pharmaceuticals Ltd

Founded in 1981, Britannia Pharmaceuticals Limited is a UK based niche pharmaceutical company specialising in products for diseases with small patient populations which are normally not developed by larger pharmaceutical companies. Subsequent to acquisition Britannia is now part of the STADA group of companies.

Events